Articles by: Timothy Dean

Road to Geisel: Class of ’21, Part 2

Road to Geisel: Class of ’21, Part 2

Meet some of the members of the Geisel School of Medicine’s Class of 2021—KC Collier, Tianrae Chu, and Allie Morgan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine.

First-year medical students Sylvia Guerra and Meredith Ryan share their thoughts about what makes the Geisel community and its admissions process stand out.

Road to Geisel: Class of ’21

Meet some of the members of the Geisel School of Medicine’s Class of 2021—Sand Mastrangelo, Shuaibu Ali, Sylvia Guerra, and Meredith Ryan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine

Photo by John Gilbert Fox

Class of 2021 Welcomed at Geisel

Ninety-two members of the Geisel School of Medicine’s 221st class were enthusiastically welcomed to Hanover by the Dartmouth community as part of this year’s orientation for incoming medical students, which runs from August 7-11.

Morgan Gilman (photo by Jon Gilbert Fox)

Grad Student Profile – Morgan Gilman: Embracing Opportunity

Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.

Photo: Shutterstock

Study Finds Legal Cannabis Laws Impact Teen Use

A new study by researchers at Dartmouth has found that adolescents living in medical marijuana states with a plethora of dispensaries are more likely to have tried new methods of cannabis use, such as edibles and vaping, at a younger age than those living in states with fewer dispensaries.

Photo: Shutterstock

New Antibody Shows Promise for Preventing RSV in Infants

Thanks to a collaboration between the pharmaceutical company MedImmune and Geisel structural biologist Jason McLellan, PhD, a long-awaited vaccine to protect infants from RSV may soon become a reality. Their findings are featured as this month’s cover story in the journal Science Translational Medicine.